

AIM-quoted Summit Corporation has revealed positive non-clinical efficacy results for SMT C1100, a treatment for Duchenne muscular dystrophy (DMD). T...


Drug discoverer Summit Corporation says that trials of its SMT 19969 C. difficile treatment show that it is superior to existing treatments. Summit ...


XP Power deputy chairman James Peters raised £1.47m from a share disposal two days after bumper interim figures from the power control products suppli...


Sausage casings manufacturer Devro reported a sharp rise in interim profit and a 40% increase in its interim dividend to 2p a share. Pre-exceptional...


Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, markets.eu@dowjones.com Contact us in London. +44-20-7842-9464 Markett...


0848 GMT [Dow Jones] Singer Capital Markets initiates coverage of Summit Corp. (SUMM.LN) with an 11p price target. The broker says the drug developmen...


LONDON (Dow Jones)--Summit Corporation PLC (SUMM.LN), a U.K. based drug discovery company, said Thursday it has a number of opportunities to deliver c...


Shares in Global Petroleum and Tower Resources slumped after the companies reported that the Avivi-1 well in Uganda had reached its total depth withou...